| Search recent Press Releases: Glaxo Group Limited-related press releases |
| Count |
Application # |
Date |
Glaxo Group Limited patents (updated weekly) - BOOKMARK this page |
| 1 | 20140200218 | 07/17/14 | Novel crystalline forms of (3r, 6r)-3-(2,3-dihydro-1h-inden-2-yl)-1-[(1r)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1s)-1-methylpropyl]-2,5-piperazinedione
|
| 2 | 20140193407 | 07/10/14 | Drug fusions and conjugates
|
| 3 | 20140187750 | 07/03/14 | Methods for selecting protease resistant polypeptides
|
| 4 | 20140179715 | 06/26/14 | 2,3-dihydroimidazo[1 ,2-c] pyrimidin-5(1 h)-one compounds use as lp-pla2 inhibitors
|
| 5 | 20140158704 | 06/12/14 | Medicament dispenser
|
| 6 | 20140140996 | 05/22/14 | Anti-serum albumin biding variable domains
|
| 7 | 20140140996 | 05/22/14 | Anti-serum albumin biding variable domains
|
| 8 | 20140116434 | 05/01/14 | Dry powder inhaler compositions
|
| 9 | 20140116434 | 05/01/14 | Dry powder inhaler compositions
|
| 10 | 20140112929 | 04/24/14 | Tumour necrosis factor receptor 1 antagonists
|
| 11 | 20140113888 | 04/24/14 | Novel combination of therapeutic agents
|
| 12 | 20140113922 | 04/24/14 | Compounds
|
| 13 | 20140112929 | 04/24/14 | Tumour necrosis factor receptor 1 antagonists
|
| 14 | 20140113888 | 04/24/14 | Novel combination of therapeutic agents
|
|
|
| 15 | 20140113922 | 04/24/14 | Compounds
|
| 16 | 20140105894 | 04/17/14 | Humanized anti-il-18 antibodies
|
| 17 | 20140105915 | 04/17/14 | Bcma (cd269/tnfrsf17) - binding proteins
|
| 18 | 20140105894 | 04/17/14 | Humanized anti-il-18 antibodies
|
| 19 | 20140105915 | 04/17/14 | Bcma (cd269/tnfrsf17) - binding proteins
|
| 20 | 20140076314 | 03/20/14 | Manifold for use in medicament dispenser
|
| 21 | 20140080863 | 03/20/14 | Muscarinic acetylcholine receptor antagonists
|
| 22 | 20140076314 | 03/20/14 | Manifold for use in medicament dispenser
|
| 23 | 20140080863 | 03/20/14 | Muscarinic acetylcholine receptor antagonists
|
| 24 | 20140056900 | 02/27/14 | Method for inhibiting binding to b-cell receptor
|
| 25 | 20140058105 | 02/27/14 | Substituted diketopiperazines and their use as oxytocin antagonists
|
| 26 | 20140050719 | 02/20/14 | Antibodies
|
| 27 | 20140051720 | 02/20/14 | N-cyclobutyl - imidazopyridine - methylamine as trpv1 antagonists
|
| 28 | 20140038989 | 02/06/14 | Tetrahydropyrazolo [1,5-a] pyrimidine as anti-tuberculosis compounds
|
| 29 | 20140023596 | 01/23/14 | Novel composition
|
| 30 | 20140024558 | 01/23/14 | Method of treatment
|
| 31 | 20140005177 | 01/02/14 | Pyridinyl- and pyrazinyl-methyloxy-aryl derivatives useful as inhibitors of spleen tyrosine kinase (syk)
|
| 32 | 20140005188 | 01/02/14 | Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
|
| 33 | 20130345465 | 12/26/13 | Process for the preparation of retigabine
|
| 34 | 20130336989 | 12/19/13 | Methods of identifying a patient population
|
|
|
| 35 | 20130315901 | 11/28/13 | Novel uses
|
| 36 | 20130317041 | 11/28/13 | Compounds
|
| 37 | 20130310281 | 11/21/13 | Novel antigen binding proteins
|
| 38 | 20130302335 | 11/14/13 | Ligands that bind tgf-beta receptor ii
|
| 39 | 20130267717 | 10/10/13 | Process for the preparation of atovaquone
|
| 40 | 20130261185 | 10/03/13 | Benzamide derivatives as ep4 receptor agonists
|
| 41 | 20130251724 | 09/26/13 | Antigen binding proteins to oncostatin m (osm)
|
| 42 | 20130253188 | 09/26/13 | Novel compounds
|
| 43 | 20130237501 | 09/12/13 | Benzofuran compounds for the treatment of hepatitis c virus infections
|
| 44 | 20130224204 | 08/29/13 | Method of treatment based on atad2 inhibitors
|
| 45 | 20130224204 | 08/29/13 | Method of treatment based on atad2 inhibitors
|
| 46 | 20130213154 | 08/22/13 | Method of determining cleanliness
|
| 47 | 20130213394 | 08/22/13 | Dispensing device
|
| 48 | 20130217658 | 08/22/13 | Pyrazole compounds acting against allergic, inflammatory and immune disorders
|
| 49 | 20130213154 | 08/22/13 | Method of determining cleanliness
|
| 50 | 20130213394 | 08/22/13 | Dispensing device
|
| 51 | 20130217658 | 08/22/13 | Pyrazole compounds acting against allergic, inflammatory and immune disorders
|
| 52 | 20130210892 | 08/15/13 | Method of treatment
|
| 53 | 20130210892 | 08/15/13 | Method of treatment
|
| 54 | 20130203705 | 08/08/13 | Pyrazole compounds acting against allergic, immune and inflammatory conditions
|
| 55 | 20130203802 | 08/08/13 | 3 -amino- pyrazole derivatives useful against tuberculosis
|
| 56 | 20130203705 | 08/08/13 | Pyrazole compounds acting against allergic, immune and inflammatory conditions
|
| 57 | 20130203802 | 08/08/13 | 3 -amino- pyrazole derivatives useful against tuberculosis
|
| 58 | 20130196412 | 08/01/13 | Magi polynucleotides, polypetides, and antibodies
|
| 59 | 20130196412 | 08/01/13 | Magi polynucleotides, polypetides, and antibodies
|
| 60 | 20130189255 | 07/25/13 | Fusions and conjugates of insulinotropic agents
|
| 61 | 20130189255 | 07/25/13 | Fusions and conjugates of insulinotropic agents
|
| 62 | 20130131338 | 05/23/13 | Substituted diketopiperazines as oxytocin antagonists
|
| 63 | 20130131338 | 05/23/13 | Substituted diketopiperazines as oxytocin antagonists
|
| 64 | 20130118132 | 05/16/13 | Machine and method for pharmaceutical and pharmaceutical-like product assembly
|
| 65 | 20130118132 | 05/16/13 | Machine and method for pharmaceutical and pharmaceutical-like product assembly
|
| 66 | 20130109690 | 05/02/13 | Novel crystalline forms of (3r, 6r)-3-(2,3-dihydro-1h-inden-2-yl)-1-[(1r)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1s)-1-methylpropyl]-2,5-piperazinedione
|
| 67 | 20130109690 | 05/02/13 | Novel crystalline forms of (3r, 6r)-3-(2,3-dihydro-1h-inden-2-yl)-1-[(1r)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1s)-1-methylpropyl]-2,5-piperazinedione
|
| 68 | 20130102783 | 04/25/13 | Substituted diketopiperazines and their use as oxytocin antagonists
|
| 69 | 20130078198 | 03/28/13 | Novel use
|
| 70 | 20130053375 | 02/28/13 | Amino-quinolines as kinase inhibitors
|
| 71 | 20130039470 | 02/14/13 | Sample plate for an x-ray powder diffraction apparatus
|
| 72 | 20130040984 | 02/14/13 | 7-(lh-pyrazol-4-yl)-1,6-naphthyridine compounds as syk inhibitors
|
| 73 | 20130030012 | 01/31/13 | Compounds
|
| 74 | 20130030015 | 01/31/13 | Muscarinic acetylcholine receptor antagonists
|
| 75 | 20130023541 | 01/24/13 | Voltage-gated sodium channel blockers
|
| 76 | 20130012491 | 01/10/13 | Pyrimidine derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
|
| 77 | 20120316202 | 12/13/12 | Compounds which have activity at m1 receptor and their uses in medicine
|
| 78 | 20120309725 | 12/06/12 | Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
|
| 79 | 20120309789 | 12/06/12 | Compounds which have activity at m1 receptor and their uses in medicine
|
| 80 | 20120288544 | 11/15/12 | Novel retigabine composition
|
| 81 | 20120277279 | 11/01/12 | Non-steroidal glucocorticoid inhibitors and their use in treating inflammation, allergy and auto-immune conditions
|
| 82 | 20120251468 | 10/04/12 | Compositions comprising alginates with high guluronic acid/mannuronic acid ratio for use in the treatment of dentine hypersensitivity
|
| 83 | 20120240742 | 09/27/12 | Novel device
|
| 84 | 20120245171 | 09/27/12 | Benzpyrazole derivatives as inhibitors of pi3 kinases
|
| 85 | 20120238559 | 09/20/12 | Novel compounds
|
| 86 | 20120238571 | 09/20/12 | Indazole derivatives as pi 3-kinase
|
| 87 | 20120232061 | 09/13/12 | Novel compounds
|
| 88 | 20120207749 | 08/16/12 | Dosing regimen
|
| 89 | 20120202811 | 08/09/12 | Novel compounds
|
| 90 | 20120157446 | 06/21/12 | Medical use
|
| 91 | 20120157491 | 06/21/12 | Muscarinic acetylcholine receptor antagonists
|
| 92 | 20120157492 | 06/21/12 | Antibiotic drug
|
| 93 | 20120149711 | 06/14/12 | Piperidine derivatives used as orexin antagonists
|
| 94 | 20120149731 | 06/14/12 | New medical use
|
| 95 | 20120128689 | 05/24/12 | Anti-il-23 immunoglobulins
|
| 96 | 20120129778 | 05/24/12 | Ligand that bind tgf-beta receptor rii
|
| 97 | 20120114647 | 05/10/12 | anti-serum album single variable domains
|
| 98 | 20120100137 | 04/26/12 | Immunoglobulins
|
| 99 | 20120101083 | 04/26/12 | S1p1 agonists comprising a bicyclic n-containing ring
|
| 100 | 20120101086 | 04/26/12 | Thiadiazole derivatives and their use for the treatment of disorders mediated by s1p1 receptors
|
| 101 | 20120101124 | 04/26/12 | 1,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonists
|
| 102 | 20120101134 | 04/26/12 | 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
|
| 103 | 20120101136 | 04/26/12 | 5-membered heteroaryl derivatives used as sphingosine 1- phosphate receptor agonists
|
| 104 | 20120065177 | 03/15/12 | Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions
|
| 105 | 20120058963 | 03/08/12 | Macrolides with anti-inflammatory activity
|
| 106 | 20120046258 | 02/23/12 | Novel crystalline pharmaceutical product
|
| 107 | 20120046469 | 02/23/12 | Process for the preparation of a biphenyl-2-yl carbamic acid ester
|
| 108 | 20120039820 | 02/16/12 | Antibacterial composition comprising 4-isopropyl-3-methylphenol and zinc ions
|
| 109 | 20120040991 | 02/16/12 | 3-azabicyclo [4.1.0] heptanes used as orexin antagonists
|
| 110 | 20120041027 | 02/16/12 | Benzimidazoles which have activity at m1 receptor and their uses in medicine
|
| 111 | 20120041028 | 02/16/12 | Benzimidazoles which have activity at m1 receptor and their uses in medicine
|
| 112 | 20120034312 | 02/09/12 | 4-isopropyl-3-methylphenol for the treatment of inflammation
|
| 113 | 20120006322 | 01/12/12 | Drug dispenser
|
| 114 | 20120004229 | 01/05/12 | Substituted diketopiperazines and their use as oxytocin antagonists
|
| 115 | 20110319371 | 12/29/11 | Pharmaceutical formulations comprising 4-hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
|
| 116 | 20110305692 | 12/15/11 | Antigen-binding contructs
|
| 117 | 20110305693 | 12/15/11 | Anitigen-binding constructs
|
| 118 | 20110288098 | 11/24/11 | Novel compounds
|
| 119 | 20110281909 | 11/17/11 | Substituted quinoline derivatives as h1 receptor antagonists
|
| 120 | 20110275655 | 11/10/11 | Pyrimidinecarboxamide derivatives as inhibitors of syk kinase
|
| 121 | 20110275661 | 11/10/11 | Tricyclic nitrogen compounds used as antibacterials
|
| 122 | 20110269738 | 11/03/11 | Compounds
|
| 123 | 20110269970 | 11/03/11 | Phenethanolamine derivatives for treatment of respiratory diseases
|
| 124 | 20110263588 | 10/27/11 | Tricyclic compounds as glutamate receptor modulators
|
| 125 | 20110253752 | 10/20/11 | Nozzle for a nasal inhaler
|
| 126 | 20110256074 | 10/20/11 | Novel use
|
| 127 | 20110245470 | 10/06/11 | Immunoglobulins
|
| 128 | 20110237792 | 09/29/11 | Quinoline derivatives and their use as 5-ht6 ligands
|
| 129 | 20110190274 | 08/04/11 | Salt of, and processes for the preparation of, 1-isopropyl-4-hexahydro-1h-1,4-diazepine
|
| 130 | 20110178063 | 07/21/11 | Benzpyrazol derivatives as inhibitors of pi3 kinases
|
| 131 | 20110166150 | 07/07/11 | Anhydrous crystal form of ovrepitant maleate
|
| 132 | 20110150871 | 06/23/11 | Treatment of an autoimmune disease using il-18 antagonists
|
| 133 | 20110152262 | 06/23/11 | Novel compounds
|
| 134 | 20110142824 | 06/16/11 | Antibodies against amyloid-beta peptide
|
| 135 | 20110144151 | 06/16/11 | Novel process, salts, composition and use
|
| 136 | 20110135695 | 06/09/11 | Oral dosage form for controlled drug release
|
| 137 | 20110130423 | 06/02/11 | Compounds which have activity at m1 receptor and their uses in medicine
|
| 138 | 20110117190 | 05/19/11 | Pharmaceutical formulations
|
| 139 | 20110118261 | 05/19/11 | Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
|
| 140 | 20110061646 | 03/17/11 | Drug dispenser
|
| 141 | 20110064740 | 03/17/11 | Antigen binding proteins
|
| 142 | 20110065725 | 03/17/11 | Triazole amide derivatives for use in therapy
|
| 143 | 20110059167 | 03/10/11 | Encapsulation of biologically active agents
|
| 144 | 20110059979 | 03/10/11 | Piperidine/cyclohexane carboxamide derivatives for use as vanilloid receptor modulators
|
| 145 | 20110045027 | 02/24/11 | Adjuvant
|
| 146 | 20110046137 | 02/24/11 | Pyrazole derivatives as p2x7 modulators
|
| 147 | 20110034524 | 02/10/11 | Hemi-fumarate salt of a 1,3,4-thiadiazolyl derivative as modulator of the sphingosine 1-phosphate receptor
|
| 148 | 20110021578 | 01/27/11 | Compounds which potentiate the ampa receptor and uses thereof in medicine
|
| 149 | 20110009394 | 01/13/11 | Tricyclic nitrogen compounds and their use as antibacterial agents
|
| 150 | 20110009631 | 01/13/11 | Phenethanolamine derivatives for treatment of respiratory diseases
|
| 151 | 20100329996 | 12/30/10 | Novel combination of therapeutic agents
|
| 152 | 20100324022 | 12/23/10 | Novel compounds
|
| 153 | 20100316579 | 12/16/10 | Novel use of alkyl phosphate esters
|
| 154 | 20100317666 | 12/16/10 | Composition comprising an nk-1 receptor antagonist and an ssri for the treatment of tinnitus and hearing loss
|
| 155 | 20100317672 | 12/16/10 | Monomaleate monohydrate salt of a 5ht1a receptor antagonist
|
| 156 | 20100308082 | 12/09/10 | Dispensing device
|
| 157 | 20100311706 | 12/09/10 | Method of treatment of allergic rhinitis
|
| 158 | 20100311734 | 12/09/10 | Spiro compounds useful as antagonists of the h1 receptor
|
| 159 | 20100303821 | 12/02/10 | Immunoglobulins
|
| 160 | 20100305107 | 12/02/10 | Quinoline derivatives and their use as 5-ht6 ligands
|
| 161 | 20100305127 | 12/02/10 | Novel compounds
|
| 162 | 20100305166 | 12/02/10 | Novel compounds
|
| 163 | 20100292224 | 11/18/10 | Isothiazolidine 1,1-dioxide and tetrahydro-2h-1,2-thiazine 1,1-dioxide derivatives as p2x7 modulators
|
| 164 | 20100292295 | 11/18/10 | 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators
|
| 165 | 20100286152 | 11/11/10 | N-phenyl hydrazides as modulators of the ghrelin receptor
|
| 166 | 20100275909 | 11/04/10 | Actuator for an inhaler
|
| 167 | 20100273853 | 10/28/10 | Novel isoindol derivatives as ep4 receptor agonists
|
| 168 | 20100267691 | 10/21/10 | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
|
| 169 | 20100267734 | 10/21/10 | N-[(3,5-dichlorophenyl)methyl]-2-(4-methyl-1-piperazinyl)-2-(1-naphthalenyl)ethanamide as ghrelin receptor modulator
|
| 170 | 20100256199 | 10/07/10 | Crystalline form of an antimalarial compound
|
| 171 | 20100256919 | 10/07/10 | Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity
|
| 172 | 20100239666 | 09/23/10 | Process for producing mouldings from (meth) acrylate copolymers by means of injection moulding
|
| 173 | 20100224185 | 09/09/10 | Actuator for an inhaler
|
| 174 | 20100222349 | 09/02/10 | Quinoline derivatives used to treat inflammatory and allergic diseases
|
| 175 | 20100216799 | 08/26/10 | Phthalazine and pyrido[3,4-d]pyridazine compounds as h1 receptor antagonists
|
| 176 | 20100216837 | 08/26/10 | Glycine transport inhibitors
|
| 177 | 20100210672 | 08/19/10 | Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors
|
| 178 | 20100203256 | 08/12/10 | Method and apparatus for the application of powder material to substrates
|
| 179 | 20100204242 | 08/12/10 | Piperazine derivative having affinity for the histamine h3 receptor
|
| 180 | 20100204273 | 08/12/10 | Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
|
| 181 | 20100197679 | 08/05/10 | Compounds
|
| 182 | 20100197699 | 08/05/10 | I-oxa-3-azaspiro (4.5) decan-2-one and 1-oxa-3, 8-diazaspiro (4.5) decan-2-one derivatives for the treatment of eating disorders
|
| 183 | 20100190764 | 07/29/10 | Novel compounds
|
| 184 | 20100184770 | 07/22/10 | Compounds
|
| 185 | 20100184996 | 07/22/10 | Process of amide formation
|
| 186 | 20100175698 | 07/15/10 | Capsule
|
| 187 | 20100174065 | 07/08/10 | Compounds
|
| 188 | 20100148091 | 06/17/10 | Method and system for rapid phase luminescense spectroscopy analysis
|
| 189 | 20100152195 | 06/17/10 | Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
|
| 190 | 20100144016 | 06/10/10 | Apparatus for the disruption of animal cells
|
| 191 | 20100144755 | 06/10/10 | Novel compounds
|
| 192 | 20100144829 | 06/10/10 | Novel receptor antagonists and their methods of use
|
| 193 | 20100145040 | 06/10/10 | Benzazepine derivatives for the treatment of neurological disorders
|
| 194 | 20100137276 | 06/03/10 | Compounds which potentiate ampa receptor and uses thereof in medicine
|
| 195 | 20100137353 | 06/03/10 | Tricyclic compounds as antibacterials
|
| 196 | 20100137378 | 06/03/10 | Pyridine compounds for the treatment of prostaglandin mediated diseases
|
| 197 | 20100137428 | 06/03/10 | Oxygen containing heterocycles as glycine transporter inhibiting compounds
|
| 198 | 20100130583 | 05/27/10 | Prolinamide derivatives as modulators of voltage-gated sodium channels
|
| 199 | 20100113521 | 05/06/10 | Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2s-phenylpiperidin-3s-yl-)
|
| 200 | 20100113528 | 05/06/10 | Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists
|
| 201 | 20100113796 | 05/06/10 | Indole derivatives as s1p1 receptor
|
| 202 | 20100105652 | 04/29/10 | Purines as cysteine protease inhibitors
|
| 203 | 20100105688 | 04/29/10 | Pharmaceutical compositions comprising 3,5-diamino-6-(2,3-dichlophenyl)-1,2,4-triazine or r(-)-2,4-diamino-5-(2,3-dichlorophenyl)-6-fluoromethyl pyrimidine and an nk1
|
| 204 | 20100105754 | 04/29/10 | 5-(4phenyl)prolinamide for treatment of epilepsy
|
| 205 | 20100087424 | 04/08/10 | Tricyclic nitrogen containing heterocycles as antibacterial agents
|
| 206 | 20100087502 | 04/08/10 | Indazoles used to treat estrogen receptor beta mediated disorders
|
| 207 | 20100087667 | 04/08/10 | Methods of synthesizing 1-(acyloxy)-alkyl carbamate prodrugs
|
| 208 | 20100081830 | 04/01/10 | Methods of synthesizing n-hydroxysuccinimidyl carbonates
|
| 209 | 20100075953 | 03/25/10 | Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
|
| 210 | 20100075982 | 03/25/10 | Pyridinone derivative for the treatment of premature ejaculation
|
| 211 | 20100068166 | 03/18/10 | Oral composition comprising dimethicone copolyol
|
| 212 | 20100069409 | 03/18/10 | "novel compounds"
|
| 213 | 20100069416 | 03/18/10 | Azabicyclo [3.1.0] hexyl derivatives as modulators of dopamine d3 receptors
|
| 214 | 20100059052 | 03/11/10 | Sheet driver for use in a drug dispenser
|
| 215 | 20100063097 | 03/11/10 | Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine d3 receptors
|
| 216 | 20100056502 | 03/04/10 | Compounds
|
| 217 | 20100056527 | 03/04/10 | Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor
|
| 218 | 20100056595 | 03/04/10 | Pyrazole derivatives as p2x7 modulators
|
| 219 | 20100048639 | 02/25/10 | Oxadiazole derivates as s1p1 receptor agonists
|
| 220 | 20100041672 | 02/18/10 | Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome
|
| 221 | 20100029699 | 02/04/10 | Matrix metalloproteinase inhibitors
|
| 222 | 20100016287 | 01/21/10 | Compounds having affinity for dopamine d3 receptor and uses thereof"
|
| 223 | 20100016371 | 01/21/10 | Indole compounds
|
| 224 | 20100010021 | 01/14/10 | Novel compounds
|
| 225 | 20100000528 | 01/07/10 | Manifold for use in medicament dispenser
|
| 226 | 20100000529 | 01/07/10 | Manifold for use in medicament dispenser
|
| 227 | 20100003420 | 01/07/10 | Medicament dispenser
|
| 228 | 20100004230 | 01/07/10 | Azatricyclic compounds and their use
|
| 229 | 20100004240 | 01/07/10 | Indole compounds
|
| 230 | 20090325952 | 12/31/09 | Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
|
| 231 | 20090326032 | 12/31/09 | Pharmaceutical compositions comprising nk1 receptor antagonists and sodium channel blockers
|
| 232 | 20090318494 | 12/24/09 | Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
|
| 233 | 20090318523 | 12/24/09 | Benzoisoindole derivatives and their use as ep4 receptor agonists
|
| 234 | 20090318530 | 12/24/09 | Pharmaceutical compositions comprising nk1 receptor antagonists and sodium channel blockers
|
| 235 | 20090312388 | 12/17/09 | Benzo [f] isoindoles as ep4 receptor agonists
|
| 236 | 20090312546 | 12/17/09 | Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
|
| 237 | 20090306052 | 12/10/09 | Indenyl derivatives and use thereof for the treatment of neurological disorders
|
| 238 | 20090298742 | 12/03/09 | Process for manufacturing lactose
|
| 239 | 20090291146 | 11/26/09 | Process for manufacturing lactose
|
| 240 | 20090291987 | 11/26/09 | Novel polymorph of (5-amino-6-methoxy-3-pyridincarbonyl) carbamic acid 2-(s)-hydroxymutilin 14-ester
|
| 241 | 20090286762 | 11/19/09 | Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions
|
| 242 | 20090275604 | 11/05/09 | M3 muscarinic acetylcholine receptor antagonists
|
| 243 | 20090270355 | 10/29/09 | Compounds
|
| 244 | 20090270510 | 10/29/09 | Glycine transport inhibitors
|
| 245 | 20090253908 | 10/08/09 | Novel m3 muscarinic acetylchoine receptor antagonists
|
| 246 | 20090236445 | 09/24/09 | Fluid dispenser
|
| 247 | 20090239846 | 09/24/09 | Novel compounds
|
| 248 | 20090232847 | 09/17/09 | Immunogenic compositions
|
| 249 | 20090227547 | 09/10/09 | Novel salt form of a beta2-adrenergic agonist quinolin-2-one derivative
|
